<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02562014</url>
  </required_header>
  <id_info>
    <org_study_id>Protocol #27112</org_study_id>
    <nct_id>NCT02562014</nct_id>
  </id_info>
  <brief_title>Role of Colonic Short Chain Fatty Acids in Obesity</brief_title>
  <official_title>Effect of Inulin and Resistant Starch on Postprandial Short Chain Fatty Acid, Glucose, Insulin and Gut Hormone Responses in Lean and Overweight Subjects.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Toronto</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Toronto</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The excess production of colonic short-chain-fatty-acids (SCFA) has been implicated in the
      promotion of obesity, but colonic fermentation of dietary-fiber to SCFA may also play a role
      in preventing diabetes. The investigators aimed to compare the effects of two fermentable
      fibers (inulin and resistant-starch) on postprandial SCFA, glucose, insulin, free-fatty acids
      (FFA) and gut hormone responses and to compare the responses in healthy overweight and obese
      (OWO) vs lean (LN) participants. Methods: Using a randomized, single blind, crossover design,
      13 OWO and 12 LN overnight fasted participants were studied on 3 separate occasions. On each
      day they consumed a 300 mL drink containing 75g glucose (Control) or 75g glucose plus 24g
      inulin (IN), or 28.2g resistant-starch (RS). A standard lunch was served 4 h after the test
      drink.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>February 2012</start_date>
  <completion_date type="Actual">January 2013</completion_date>
  <primary_completion_date type="Actual">July 2012</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Incremental area under the serum acetate response curve</measure>
    <time_frame>For 6 hours after consuming the test meal</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Incremental area under the serum propionate response curve</measure>
    <time_frame>For 6 hours after consuming the test meal</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incremental area under the serum butyrate response curve</measure>
    <time_frame>For 6 hours after consuming the test meal</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incremental area under the breath hydrogen response curve</measure>
    <time_frame>For 6 hours after consuming the test meal</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incremental area under the breath methane response curve</measure>
    <time_frame>For 6 hours after consuming the test meal</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incremental area under the serum glucose response curve</measure>
    <time_frame>For 4 hours after consuming the test meal</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incremental area under the serum glucose response curve</measure>
    <time_frame>For 2 hours after consuming the standard lunch</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incremental area under the serum insulin response curve</measure>
    <time_frame>For 4 hours after consuming the test meal</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incremental area under the serum insulin response curve</measure>
    <time_frame>For 2 hours after consuming the standard lunch</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incremental area under the serum c-peptide response curve</measure>
    <time_frame>For 4 hours after consuming the test meal</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incremental area under the serum c-peptide response curve</measure>
    <time_frame>For 2 hours after consuming the standard lunch</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Total area under the serum free-fatty acid response curve</measure>
    <time_frame>For 4 hours after consuming the test meal</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Total area under the serum free-fatty acid response curve</measure>
    <time_frame>For 2 hours after consuming the standard lunch</time_frame>
  </secondary_outcome>
  <other_outcome>
    <measure>Incremental area under the serum glucagon-like peptide-1 response curve</measure>
    <time_frame>For 4 hours after consuming the test meal</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Incremental area under the serum glucagon-like peptide-1 response curve</measure>
    <time_frame>For 2 hours after consuming the standard lunch</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Incremental area under the serum peptide-YY response curve</measure>
    <time_frame>For 4 hours after consuming the test meal</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Incremental area under the serum peptide-YY response curve</measure>
    <time_frame>For 2 hours after consuming the standard lunch</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Incremental area under the serum ghrelin response curve</measure>
    <time_frame>For 4 hours after consuming the test meal</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Incremental area under the serum ghrelin response curve</measure>
    <time_frame>For 2 hours after consuming the standard lunch</time_frame>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">25</enrollment>
  <condition>Obesity</condition>
  <arm_group>
    <arm_group_label>Lean</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Participants with body mass index &lt;=25</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Overweight</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Participants with body mass index &gt;25</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Glucose</intervention_name>
    <description>75g glucose</description>
    <arm_group_label>Lean</arm_group_label>
    <arm_group_label>Overweight</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Inulin</intervention_name>
    <description>75g glucose plus 24g inulin</description>
    <arm_group_label>Lean</arm_group_label>
    <arm_group_label>Overweight</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Resistant Starch</intervention_name>
    <description>75g glucose plus 28.2g resistant starch</description>
    <arm_group_label>Lean</arm_group_label>
    <arm_group_label>Overweight</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  non-pregnant

          -  body mass index &gt;=20 and &lt;=35

        Exclusion Criteria:

          -  history of diabetes mellitus

          -  history of cardiovascular disease

          -  history of bowel disease

          -  history of kidney disease

          -  history of liver disease

          -  use of antibiotics within 3 months of enrolment

          -  unusual dietary habits

          -  fasting glucose &gt;6.9mmol/L

          -  hematocrit below normal range for age and sex
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Thomas MS Wolever, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Toronto</affiliation>
  </overall_official>
  <verification_date>September 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 25, 2015</study_first_submitted>
  <study_first_submitted_qc>September 28, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 29, 2015</study_first_posted>
  <last_update_submitted>September 28, 2015</last_update_submitted>
  <last_update_submitted_qc>September 28, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 29, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Toronto</investigator_affiliation>
    <investigator_full_name>Thomas Wolever</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Obesity</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

